251 related articles for article (PubMed ID: 32977154)
1. Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use.
Alzhrani A; Bottomley M; Wood K; Hester J; Issa F
Cell Immunol; 2020 Nov; 357():104214. PubMed ID: 32977154
[TBL] [Abstract][Full Text] [Related]
2. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
Putnam AL; Safinia N; Medvec A; Laszkowska M; Wray M; Mintz MA; Trotta E; Szot GL; Liu W; Lares A; Lee K; Laing A; Lechler RI; Riley JL; Bluestone JA; Lombardi G; Tang Q
Am J Transplant; 2013 Nov; 13(11):3010-20. PubMed ID: 24102808
[TBL] [Abstract][Full Text] [Related]
3. Donor reactive regulatory T cells.
Feng G; Chan T; Wood KJ; Bushell A
Curr Opin Organ Transplant; 2009 Aug; 14(4):432-8. PubMed ID: 19448539
[TBL] [Abstract][Full Text] [Related]
4. Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells.
Landwehr-Kenzel S; Issa F; Luu SH; Schmück M; Lei H; Zobel A; Thiel A; Babel N; Wood K; Volk HD; Reinke P
Am J Transplant; 2014 Mar; 14(3):594-606. PubMed ID: 24467477
[TBL] [Abstract][Full Text] [Related]
5. Generation of Human Alloantigen-Specific Regulatory T Cells Under Good Manufacturing Practice-Compliant Conditions for Cell Therapy.
Cheraï M; Hamel Y; Baillou C; Touil S; Guillot-Delost M; Charlotte F; Kossir L; Simonin G; Maury S; Cohen JL; Lemoine FM
Cell Transplant; 2015; 24(12):2527-40. PubMed ID: 25198125
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T-cell therapy for transplantation: how many cells do we need?
Tang Q; Lee K
Curr Opin Organ Transplant; 2012 Aug; 17(4):349-54. PubMed ID: 22790069
[TBL] [Abstract][Full Text] [Related]
7. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
8. Treg Therapy for the Induction of Immune Tolerance in Transplantation-Not Lost in Translation?
Pilat N; Steiner R; Sprent J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675265
[TBL] [Abstract][Full Text] [Related]
9. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
10. Immunologic unresponsiveness to alloantigen in vivo: a role for regulatory T cells.
Wood KJ; Bushell A; Jones ND
Immunol Rev; 2011 May; 241(1):119-32. PubMed ID: 21488894
[TBL] [Abstract][Full Text] [Related]
11. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
[TBL] [Abstract][Full Text] [Related]
12. [Regulatory T cell based transplant tolerance--freedom from immunosuppression].
Koshiba T; Ito A; Li Y; Wu Y; Takemura M; Sakaguchi S
Nihon Rinsho; 2007 Mar; 65(3):557-67. PubMed ID: 17354576
[TBL] [Abstract][Full Text] [Related]
13. Alloantigen-specific CD4(+) regulatory T cells induced in vivo by ultraviolet irradiation after alloantigen immunization require interleukin-10 for their induction and activation, and flexibly mediate bystander immunosuppression of allograft rejection.
Hori T; Kuribayashi K; Saito K; Wang L; Torii M; Uemoto S; Kato T
Transpl Immunol; 2015 Jun; 32(3):156-63. PubMed ID: 25861842
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells for tolerance.
Kawai K; Uchiyama M; Hester J; Wood K; Issa F
Hum Immunol; 2018 May; 79(5):294-303. PubMed ID: 29288698
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
[TBL] [Abstract][Full Text] [Related]
16. T regulatory cell therapy in transplantation: stability, localization and functional specialization.
MacDonald KG; Orban PC; Levings MK
Curr Opin Organ Transplant; 2012 Aug; 17(4):343-8. PubMed ID: 22790068
[TBL] [Abstract][Full Text] [Related]
17. Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.
Mathew JM; Voss JH; McEwen ST; Konieczna I; Chakraborty A; Huang X; He J; Gallon L; Kornbluth RS; Leventhal JR
Sci Rep; 2018 Jan; 8(1):1136. PubMed ID: 29348660
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients.
Siemeni T; Knöfel AK; Madrahimov N; Sommer W; Avsar M; Salman J; Ius F; Frank N; Büchler G; Jonigk D; Jansson K; Maus U; Tudorache I; Falk CS; Haverich A; Warnecke G
Am J Transplant; 2016 Nov; 16(11):3150-3162. PubMed ID: 27273729
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells as therapeutic cells.
Sagoo P; Lombardi G; Lechler RI
Curr Opin Organ Transplant; 2008 Dec; 13(6):645-53. PubMed ID: 19060557
[TBL] [Abstract][Full Text] [Related]
20. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
